Expert Groups

To provide up-to-date, innovative strategic feasibility advice a network of Experts has been set-up. These Experts are divided into Expert Groups based on paediatric subspecialties and medical-scientific expertise.

Current standing Expert Groups are:

  • Adolescent Medicine
  • Cardiology
  • Endocrinology & Diabetes
  • Developmental pharmacology
  • Ethics
  • Formulations
  • Gastroenterology & Hepatology
  • Health Technology Assessment
  • Infectious diseases & Vaccinology
  • Intensive care
  • Metabolic diseases
  • Neonatology
  • Nephrology
  • Neuromuscular diseases
  • Neuroscience & Epilepsy
  • Oncology (incl. haematology)
  • Pharmacogenomics and other Omics technologies
  • Pharmacometrics
  • Pharmacovigilance
  • PPI (carers, parents, patients, patient organisations)
  • Psychiatry
  • Respiratory (incl. pulmonology)
  • Rheumatology & Autoimmune diseases
  • RSV
  • Study design & Clinical trial methodology
  • If a specific request requires expertise that is not available in our current network of Experts, additional Experts can be assigned via the extended network of c4c.

    Catch on the latest news for Strategic Feasibility Advisory Service